As the clinical trials industry slowly starts to transition to the COVID-19 “new normal,” sites and sponsors need to ask some tough questions, including who will bear the cost of restart, what staffing changes may be needed and what new technologies and skills will be required. Read More
Despite the increasing complexity of clinical trials and the availability of portable technology to help researchers access key protocol information on the fly, investigators and staff at clinical sites continue to show a marked tendency toward the old school, seeming to prefer to rely on printouts and workstation desktops to access protocol information. Read More
